Pfizer Issue Analysis (NYSE:PFE)
Like Brian Dean

Pfizer Issue Analysis (NYSE:PFE)

Pfizer Issue Analysis (NYSE:PFE)


Published: November 30, 2015 7 0 4.5K
By: Brian Dean, Cal Poly Pomona College of Business Administration
Category: Finance
Hashtags: #Analysis #charting #College_to_career #Economics #Finance #Financial #FinancialPlanning #FinancialServices #forecasting #issueanalysis #Stocks

This is an issue analysis on Pfizer I just completed for my Accounting class. I am very proud of how the project turned out, and was pleased to see that my conclusion aligned nicely with, albeit slightly higher than, the mean 12-month forecast consensus of $39.50. ( There is definitely room for improvement, and I enjoyed it so much I'll be doing more company analyses on my own once the 2015 annual reports roll out! (This is NOT a recommendation to buy or sell, all information is intended for educational purposes only.)


PfizerReportFinalBrianDean.pdf 905.4 KB


Royce Rowan Adam Markowitz David Burrescia Bethany Rubin Portfolium Team Brian Dean